Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C38H69NO14 |
| Molecular Weight | 763.9528 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 19 / 19 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@]1(C)C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@H](OC(=O)[C@@H]2C)[C@@H](C)O)OC)O[C@@H](C)[C@@H]1O
InChI
InChIKey=BLPFDXNVUDZBII-KTDRUCRASA-N
InChI=1S/C38H69NO14/c1-18-16-37(9,48-14)32(53-35-28(42)25(39(11)12)15-19(2)49-35)21(4)29(51-26-17-36(8,47-13)31(44)24(7)50-26)22(5)34(45)52-33(23(6)40)38(10,46)30(43)20(3)27(18)41/h18-26,28-33,35,40,42-44,46H,15-17H2,1-14H3/t18-,19-,20+,21+,22-,23-,24+,25+,26+,28-,29+,30-,31+,32-,33-,35+,36-,37-,38+/m1/s1
| Molecular Formula | C38H69NO14 |
| Molecular Weight | 763.9528 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 19 / 19 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 20:30:37 GMT 2025
by
admin
on
Wed Apr 02 20:30:37 GMT 2025
|
| Record UNII |
QS9JUX3AKY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
QS9JUX3AKY
Created by
admin on Wed Apr 02 20:30:37 GMT 2025 , Edited by admin on Wed Apr 02 20:30:37 GMT 2025
|
PRIMARY | |||
|
13921565
Created by
admin on Wed Apr 02 20:30:37 GMT 2025 , Edited by admin on Wed Apr 02 20:30:37 GMT 2025
|
PRIMARY | |||
|
116836-41-0
Created by
admin on Wed Apr 02 20:30:37 GMT 2025 , Edited by admin on Wed Apr 02 20:30:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MIC | BIOLOGICAL |
|
PATHOGEN: S. PYOGENES, S. PNEUMONIAE, H. PYLORI |
|||
| Biological Half-life | PHARMACOKINETIC |
|
14-OH-CLARITHROMYCIN |
|||
| MIC | BIOLOGICAL |
|
PATHOGEN: S. AUREUS |
|||
| MIC | BIOLOGICAL |
|
PATHOGEN: H. INFLUENZAE |
|||
| MIC | BIOLOGICAL |
|
SUSCEPTIBILITY: SUSCEPTIBLE |
|||
| MIC | BIOLOGICAL |
|
SUSCEPTIBILITY: INTERMEDIATE |
|||
| MIC | BIOLOGICAL |
|
PATHOGEN: H. INFLUENZAE |
|||
| Biological Half-life | PHARMACOKINETIC |
|
||||
| MIC | BIOLOGICAL |
|
PATHOGEN: S. AUREUS |
|||
| MIC | BIOLOGICAL |
|
PATHOGEN: S. PYOGENES, S. PNEUMONIAE |
|||
| MIC | BIOLOGICAL |
|
SUSCEPTIBILITY: RESISTANT |
|||
| Tmax | PHARMACOKINETIC |
|
FORMULATION: IMMEDIATE RELEASE |
|||
| Tmax | PHARMACOKINETIC |
|
FORMULATION: EXTENDED RELEASE |
|||
| ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|